ABAbbVie ABBV · NYSE
$285.51 +0.11% (+$0.32)
- Market cap
- $499.7B
- Enterprise value
- $564.0B
- P/E
- 79.1x
- Forward P/E
- 20.2x
- PEG
- -
- P/S
- 7.8x
- P/FCF
- 25.4x
- EV/EBITDA
- 26.6x
- ROIC
- 13.5%
- Bruto marža
- 71.5%
- Neto marža
- 9.8%
- Dividend yield
- 2.45%
- Payout ratio
- 193.7%
- Neto dolg/EBITDA
- 3.0x
- Beta
- 0.28
- Free float
- 99.8%
O podjetju
AbbVie (ABBV) is a global pharmaceutical company specializing in the development and manufacturing of innovative medicines. Their portfolio includes drugs in the areas of immunology, oncology, neuroscience, and other therapeutic areas. With strong research and development capabilities, AbbVie offers a promising investment opportunity for long-term focused investors in the healthcare sector. Add ABBV stock to your watchlist on Bulios and stay informed about the latest news and innovations in the pharmaceutical industry.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Michael
Employees
57,000
Headquarters
North Chicago
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke